PCN105 Economic Evaluation of Panitumumab and Cetuximab in the Treatment of Patients with EGFR Expressing mCRC with Non-Mutated (Wild-Type) KRAS in Greece: A Cost Minimization Analysis

✍ Scribed by Fragoulakis, V.; Papagiannopoulou, V.; Kourlaba, G.; Ducournau, P.; Maniadakis, N.

• Book ID: 122322437
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 61 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.08.1206